MOG Antibody Disease (MOGAD) RelapsesMOG Antibody Disease (MOGAD) relapses are one of a patient's biggest challenges. In this blog post, you will Read More
Satralizumab (Meteroid) Clinical Trial The hunt for the first-ever approved treatment for MOG Antibody Disease continues with another phase 3 clinical trial Read More
Grief with MOG Antibody DiseaseA diagnosis of MOG Antibody Disease (MOGAD) can be overwhelming and trigger grief. Grief is a strong, often Read More
Fatigue in MOG Antibody Disease Research – MSJ PublicationLast week we were featured in our first-ever MOG Antibody Disease research article! The results of the Ignition Read More
Fatigue in MOGAD – Ignition Survey #2 ResultsIn collaboration with The MOG Project, MyMyelitis created the Ignition Survey 2 to explore fatigue in MOG Antibody Disease (MOGAD) Read More
Rozanolixizumab – A New Treatment for MOG Antibody Disease?The first ever MOG Antibody Disease phase 3 clinical trial is now taking place. A new drug called Read More
